Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study

The introduction of immunotherapy targeting the programmed death-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis has represented a turning point in the treatment of HNSCC. Harmonization studies comparing the different antibodies and immunohistochemistry platforms available for the evaluation of PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerini Rocco, Elena, Eccher, Albino, Girolami, Ilaria, Graziano, Paolo, Fontanini, Gabriella, Vigliar, Elena, Troncone, Giancarlo, Barberis, Massimo, Morbini, Patrizia, Martini, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871075/
https://www.ncbi.nlm.nih.gov/pubmed/35204568
http://dx.doi.org/10.3390/diagnostics12020477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871075/
https://www.ncbi.nlm.nih.gov/pubmed/35204568
http://dx.doi.org/10.3390/diagnostics12020477

Ejemplares similares